RA Capital Management, LLC, 10% Owner at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 132,833 shares at $28.80 ($3.8M) on 2010-02-03, disclosed to the SEC on 2010-02-08.
Open-market sale of $3.8M BSTC by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |